Keyphrases
Protective Effect
100%
Alpha-toxin
100%
Skin Structure Infections
100%
Human Antibody
100%
Acute Bacterial Skin
100%
Toxin Effects
100%
Methicillin-resistant Staphylococcus Aureus
28%
MEDI4893
28%
USA300
28%
Monoclonal Antibody
14%
United States
14%
Neutralizing Antibodies
14%
Rabbit Model
14%
Staphylococcus Aureus
14%
Disease Severity
14%
Therapeutic Agents
14%
Adjunctive Therapy
14%
New Therapeutic Strategies
14%
Immunotherapeutics
14%
Gene Knockout
14%
Infection Model
14%
Wild Strain
14%
Linezolid
14%
Isogenic
14%
Staphylococcal Infections
14%
Immunoprophylaxis
14%
Superantigen
14%
Severe Infection
14%
Pore-forming
14%
Leukocidin
14%
Bicomponent
14%
Erythema
14%
High Standards
14%
Toxin Genes
14%
Induration
14%
Large-scale Epidemics
14%
Subcutaneous Hemorrhage
14%
Immunology and Microbiology
Neutralization
100%
Skin Structure
100%
Immunology
100%
Wild Type
28%
Methicillin-Resistant Staphylococcus Aureus
28%
Suvratoxumab
28%
Staphylococcus Aureus
14%
Leporidae
14%
Gene Targeting
14%
Neutralizing Antibody
14%
Type Strain
14%
Rabbit Model
14%
Gene Knockout
14%
Antitoxin
14%
Superantigen
14%
Human Monoclonal Antibody
14%
Immunomodulating Drugs
14%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
100%
Alpha Toxin
100%
Methicillin-Resistant Staphylococcus Aureus
22%
Suvratoxumab
22%
Disease
11%
Neutralizing Antibody
11%
Leporidae
11%
Staphylococcus Aureus
11%
Linezolid
11%
Antitoxin
11%
Rabbit Model
11%
Staphylococcal Infection
11%
Human Monoclonal Antibody
11%
Leukocidin
11%
Subcutaneous Hemorrhage
11%
Erythema
11%
Superantigen
11%
Immunomodulating Agent
11%